AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
At close
$175.30
−$0.05 (−0.03%) Close
Pre-market$175.35
+$0.05 (+0.03%) 2:28 AM ET
Prev closePrevC$175.35
OpenOpen$175.30
Day highHigh$175.30
Day lowLow$175.30
VolumeVol121
Avg volAvgVol1,782,207
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$9.42B
P/E ratio
-16.58
FY Revenue
$2.18B
EPS
-10.57
Gross Margin
49.33%
Sector
Healthcare
AI report sections
MIXED
MASI
Masimo Corporation
Masimo’s share price has moved sharply higher in recent months, with strong 1–6 month returns and a price near the upper end of its 52‑week range, while technical indicators show an overbought, momentum-driven advance. At the same time, TTM profitability is negative and valuation multiples on sales, EBITDA, and free cash flow are elevated, indicating that the current price embeds optimistic expectations despite weak earnings. The backdrop is influenced by a proposed all‑cash acquisition at a modest premium to the latest price and broadly positive recent news sentiment, which appears to be anchoring near-term price behavior.
AI summarized at 6:07 PM ET, 2026-02-18
AI summary scores
INTRADAY:78SWING:74LONG:39
Volume vs average
Intraday (cumulative)
−64% (Below avg)
Vol/Avg: 0.36×
RSI
76.22(Overbought)
Overbought (>70)
0255075100
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.02 Signal: -0.01
Short-Term
+3.21 (Strong)
MACD: 10.40 Signal: 7.19
Long-Term
+3.83 (Strong)
MACD: 9.74 Signal: 5.91
Intraday trend score
50.92
LOW50.92HIGH68.92
Latest news
MASI•12 articles•Positive: 8Neutral: 0Negative: 4
NegativeBenzinga• Prnewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KW, MASI, MCW, and JFB
Monteverde & Associates PC, a class action law firm, is investigating four merger and acquisition transactions: Kennedy-Wilson Holdings' sale to a consortium for $10.90/share, Masimo Corporation's acquisition by Danaher for $180.00/share, Mister Car Wash's sale to MCW Parent LP for $7.00/share, and JFB Construction's merger with Xtend AI Robotics where JFB shareholders will own approximately 19.9% of the combined entity.
Company is under class action investigation related to its acquisition by Danaher, indicating potential shareholder disputes over transaction valuation or terms.
NegativeGlobeNewswire Inc.• Halper Sadeh Llc
Halper Sadeh LLC is Investigating Whether VRME, MASI, VAL are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties. VerifyMe Inc. is under scrutiny for its merger with Open World Ltd, Masimo Corporation for its $180 per share sale to Danaher Corporation, and Valaris Limited for its stock-for-stock transaction with Transocean Ltd. The firm is seeking increased consideration and additional disclosures on behalf of shareholders.
VRMEMASIVALVAL.WSmerger investigationshareholder rightsfiduciary dutysecurities law
Sentiment note
Subject to investigation regarding whether the $180 per share sale to Danaher represents a fair deal, with concerns that insiders may receive disproportionate benefits.
Danaher agreed to acquire Masimo Corporation for $180 per share in an all-cash deal valued at $9.9 billion. The acquisition is expected to be accretive to earnings by $0.15-$0.20 in the first full year and approximately $0.70 by the fifth year, with projected annual synergies exceeding $175 million. Analysts view the deal as having sound financial rationale with strong recurring revenue and margin improvement potential.
DHRMASIacquisitionM&AMasimoDanahersynergiesEBITDA
Sentiment note
Masimo shareholders will receive $180 per share in cash, representing a premium acquisition price. The company is expected to generate over $530 million in EBITDA in 2027 under Danaher's ownership and will operate as a standalone company within the Diagnostics segment, maintaining operational independence while benefiting from synergies.
PositiveBenzinga• Vandana Singh
Masimo Stock Soars As Danaher Closes In On Blockbuster Deal
Danaher Corp. is reportedly nearing a $9.9 billion acquisition of Masimo Corp., with an announcement potentially coming as early as Tuesday. The deal represents a significant premium to Masimo's $7 billion market cap and follows governance changes driven by activist investors. Masimo shares surged 34.51% on the news, while Danaher shares fell 5.22% in premarket trading.
Masimo shares surged 34.51% on the acquisition news. The $9.9 billion deal represents a significant premium to the company's market cap, providing an exit for shareholders after years of underperformance (50% decline over five years) and strategic missteps.
Medical Device Connectivity Market is expected to generate a revenue of USD 13.4 Billion by 2032, Globally, at 23.40% CAGR: Verified Market Research®
The global Medical Device Connectivity Market is projected to grow at a CAGR of 23.40% from 2026 to 2032, expanding from USD 2.49 Billion in 2024 to USD 13.4 Billion by 2032. Growth is driven by increasing demand for IoT-enabled healthcare systems, remote patient monitoring, and favorable regulatory frameworks, though high implementation costs and cybersecurity concerns present challenges.
Key player in medical device connectivity market with opportunities in remote patient monitoring and connected device solutions.
PositiveGlobeNewswire Inc.• Towards Healthcare
Pulse Oximeters Market at the Heart of Remote Care: A USD 6.76 Billion Growth Opportunity by 2034
The global pulse oximeter market is valued at USD 3.8 billion in 2025 and is expected to grow to USD 6.76 billion by 2034 at a 6.64% CAGR. North America currently dominates the market, while Asia-Pacific is experiencing rapid growth. Key drivers include rising chronic respiratory diseases, remote patient monitoring advancements, and wearable technology innovations. However, the market faces challenges from accuracy issues with darker skin tones and competition from smartwatches.
Masimo SET technology is highlighted as a sophisticated sensor solution driving North America's market dominance with advanced wireless connectivity and AI integration.
PositiveBenzinga• Vandana Singh
Masimo Pitches 2028 Plan With 30% Operating Margins
Masimo outlined its long-term strategy at the 2025 Investor Day, projecting 7-10% revenue growth and 30% operating margins by 2028. The company aims for $8.00 adjusted EPS and expects to generate $1 billion in operating cash flow from 2026-2028.
Strong financial projections, beating earnings expectations, and confident leadership statement about market positioning
PositiveBenzinga• Mohd Haider
iPhone Pocket, China Sales, $600 Million Patent Case And More: This Week In Appleverse
Apple experienced significant developments including a record-breaking streaming drama, launching an iPhone Pocket accessory, strengthening sales in China, and being ordered to pay $634 million in a patent infringement case.
Won patent infringement case against Apple, receiving $634 million in damages
PositiveGlobeNewswire Inc.• Precedence Research
Neonatal Infant Care Market Size Worth USD 6.70 Billion by 2034 Driven by Rising Preterm Birth Rates and Growing Demand for Advanced NICU Technologies
The global neonatal infant care market is projected to grow from $3.63 billion in 2025 to $6.70 billion by 2034, driven by rising preterm birth rates and advanced NICU technologies. North America leads the market, while Asia Pacific shows the fastest growth.
Provides non-invasive monitoring technologies like pulse oximetry and brain function monitoring for neonatal patients
PositiveGlobeNewswire Inc.• Mark Groves
Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies
Philips and Masimo renewed their multi-year strategic collaboration to develop next-generation patient monitoring solutions, focusing on integrating advanced monitoring technologies and expanding access to connected healthcare innovations.
Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Masimo, Fidelity National Information, and Super Micro Computer —Long-Term Investors are Encouraged to Contact the Firm
Law firm Johnson Fistel is investigating potential legal violations by officers and directors of several companies, including Elanco Animal Health, Masimo, Fidelity National Information Services, and Super Micro Computer, based on alleged misleading statements and corporate misconduct.
Accusations of misleading investors about sales pipeline and revenue forecasting
NegativeGlobeNewswire Inc.• Johnson Fistel, Pllp
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
Johnson Fistel, PLLP, a shareholder rights law firm, is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.
MASIMasimo Corporationbreach of fiduciary dutiesshareholder rights
Sentiment note
The article indicates that Johnson Fistel is investigating potential breaches of fiduciary duties by Masimo's directors and officers, suggesting potential wrongdoing or mismanagement within the company.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal